Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quipt Home Medical Corp T.QIPT

Alternate Symbol(s):  QIPT

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.


TSX:QIPT - Post by User

Bullboard Posts
Post by BCBABY2014on Apr 03, 2016 7:44pm
200 Views
Post# 24726003

repost for who not have chance to read yet

repost for who not have chance to read yet
Access Issues and High Mortality Linked to Medicare Bidding Program for Medical Supplies AAHOMECARE ECHOES CALL FOR STRONGER OVERSIGHT AND MONITORING OF HEALTH OUTCOMES UNDER CMS COMPETITIVE BIDDING PROGRAM MON, MARCH 21, 2016 WASHINGTON, DC A leading scientific journal is publishing a study finding that Medicares competitive bidding program for home medical equipment and supplies caused adverse health outcomes, including increased hospitalization and death, of diabetic Medicare beneficiaries nationwide. According to the findings to be released by the studys sponsor, theNational Minority Quality Forum, the competitive bidding program, originally envisioned as a cost-savings measure, is also driving up costs in the form of avoidable hospital bills and exposing beneficiaries to much higher out-of-pocket costs for those unnecessary inpatient stays. The peer-reviewed study builds on concerns for the bidding program first raised by the Government Accountability Office in a 2012 report that questioned the Centers for Medicare and Medicaid Services (CMS) safety monitoring methods for the program. Working with leading endocrinologists, the study finds that the bidding program has disrupted diabetic patients ability to access diabetes testing supplies and that this disruption can be associated with increases in deaths, higher hospitalization rates and inpatient costs. This study definitively shows that the competitive bidding program for home medical equipment is adversely affecting the health and financial well-being of diabetic Medicare beneficiaries, said Tom Ryan, president and CEO of the American Association for Homecare. We echo the Forums call to suspend the diabetic supplies component of the program until CMS can demonstrate its ability to effectively monitor the health outcomes stemming from the competitive bidding program. The findings are especially timely in light of CMS recent release of new pricing cuts set to go into effect under the competitive bidding program that significantly reduce reimbursement for test strips and other diabetic supplies, Ryan added. These drastic cuts will almost certainly drive companies from the diabetic market, ultimately resulting in even further access issues for diabetic patients. This study, coming from highly-qualified researchers and subject to rigorous peer review, should serve as a wake-up call to policy makers who have dismissed reports the adverse effects of the bidding program on Medicare beneficiaries, Ryan concluded. We need action today that will make sure the bidding program doesnt cause more harm to the millions of seniors and individuals with disabilities or chronic conditions who rely on home medical equipment. The ahead of print article "Impact of CMS Competitive Bidding Program on Medicare Beneficiary Safety and Access to Diabetes Testing Supplies: A Retrospective, Longitudinal Analysis"can be found here; the full study is set for publication in the April issue of theJournal of Diabetes Care. The American Association for Homecare represents durable medical equipment providers, manufacturers, and others in the homecare community that serve the medical needs of millions of Americans who require oxygen systems, wheelchairs, medical supplies, inhalation drug therapy, and other medical equipment and services in their homes. Members operate more than 3,000 homecare locations in all 50 states. Visitwww.aahomecare.org.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse